We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Vasopressin Is Best Drug for Some Cases of Cardiac Arrest

By HospiMedica staff writers
Posted on 21 Jan 2004
A study has found that in certain patients with cardiac arrest, vasopressin is better than adrenaline, the standard emergency treatment. The results were reported in the January 8, 2004, issue of The New England Journal of Medicine.

The study involved 1,186 people with cardiac arrest. The overall survival rate for the two drugs was the same. However, in patients with asystole, in which pulse and electrical activity have ceased, 12 patients out of 257 taking vasopressin survived, while only four of 262 taking adrenaline survived. Almost two-thirds of all patients in the study required more than two doses of medicine to restart their hearts. Of these, almost 23 of 369 survived who were given vasopressin first, but only six of the 355 survived who were given adrenaline first. The study did not include patients revived by electrical shocks but did include patients for whom defibrillation failed or was inappropriate. Patients in the study also received emergency treatment, including rescue breathing and chest compressions.

The study was conducted by Dr. Volker Wenzel, University of Innsbruck (Austria). According to Dr.Wenzel, vasopressin shifts the flow of blood away from the skin, legs, abdomen, and muscles, and toward the brain and heart. He reported that he now gives both drugs to all adults with cardiac arrest.




Related Links:
U. of Innsbruck

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Portable X-ray Unit
AJEX140H
New
Portable Patient Lift
Maxi Move

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization